e.g. Tata motors, Reliance MF, 500570

GlaxoSmithKline Pharmaceuticals Ltd.

500660  GLAXO   Group (A)

17 Apr,15:47
2451.80 32.70 (1.35%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
BSE  |  NSE
zoomZoomRefresh
Day
Wk
Mn
6Mn
Yr
Volume

1,739

Prev close

2,419.10

Day's H/L (Rs.)

2,465.00 - 2,418.50

52wk H/L (Rs.)

3,515.95 - 2,218.00

Mkt Cap (Rs. Cr)

41,533.50

GlaxoSmithKline Pharmaceuticals Ltd.

InvestChart

GlaxoSmithKline Pharmaceuticals Ltd.

GLAXO

17 Apr,15:57
2453.90 34.10 (1.41%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
BSE  |  NSE
ZoomRefresh
Day
Wk
Mn
6Mn
Yr
Volume

42,722

Prev close

2419.80

Day's H/L (Rs.)

2,465.40 - 2,410.00

52wk H/L (Rs.)

3,515.70 - 2,217.60

Turnover (Rs. Lacs)

104,658,219.50

GlaxoSmithKline Pharmaceuticals Ltd.

InvestChart

Financial Results of GlaxoSmithKline Pharmaceuticals Ltd.

(Rs. Crore)
Mar ' 25Mar ' 24Mar ' 23Mar ' 22Mar ' 21
Sales3,723.493,407.253,216.343,217.513,193.73
Operating profit1,169.29900.65799.41755.83694.95
Interest1.311.801.811.993.53
Gross profit1,310.541,022.33899.12830.06801.61
EPS (Rs)54.2534.5135.8799.7921.11

See More >

Compare 'GlaxoSmithKline Pharmaceuticals Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,693.15
  • Compare
  • Divi's Laboratories Ltd.
  • 6,297.50
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 1,221.25
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 4,156.35
  • Compare
  • Zydus Lifesciences Ltd.
  • 939.20
  • Compare
  • Max Healthcare Institute Ltd.
  • 990.85
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,555.95
  • Compare

Statements:

Balance Sheet  |  P&L  |  Cash Flow  |  Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

GlaxoSmithKline Pharmaceuticals Ltd. PERFORMANCE SNAPSHOT

If you had invested Rs.
in GlaxoSmithKline Pharmaceuticals Ltd.,
  ago

You would have Rs. 000.00

Add to Portfolio

Report Card

PE Ratios
45.19
EPS (Rs.)
54.25
Sales (Rs. Cr)
1,022.59
Face Value (Rs.)
10
Net Profit Margin (%)
24.68
Last Bonus
1:1
Last Dividend (%)
420
Return on Average Equity
47.14

Frequently Asked Questions

Q: What is the current share price of GlaxoSmithKline Pharmaceuticals Ltd.?

A: The current share price of GlaxoSmithKline Pharmaceuticals Ltd. is ₹ 2451.80 (for BSE as on 17 Apr,15:47). The 52-week range is ₹ 3,515.95 - 2,218.00. Prices are updated based on live market data.

Q: What is the market capitalization of GlaxoSmithKline Pharmaceuticals Ltd.?

A: GlaxoSmithKline Pharmaceuticals Ltd. has a market capitalization of ₹ 41,533.50 Cr, making it a company.

Q: What is the PE ratio of GlaxoSmithKline Pharmaceuticals Ltd.?

A: The Price-to-Earnings (PE) ratio of GlaxoSmithKline Pharmaceuticals Ltd. is 45.19, indicating its valuation relative to earnings.

Q: Is GlaxoSmithKline Pharmaceuticals Ltd. a good investment?

A: GlaxoSmithKline Pharmaceuticals Ltd. is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.

Q: Does GlaxoSmithKline Pharmaceuticals Ltd. pay dividends?

A: Yes. GlaxoSmithKline Pharmaceuticals Ltd. pay dividends. The latest dividend yield is 420%.

Q: What are the latest financial results of GlaxoSmithKline Pharmaceuticals Ltd.?

A: GlaxoSmithKline Pharmaceuticals Ltd. has reported its latest annual results with revenue of ₹ 3,723.49 and net profit/loss of ₹ 919.06.

Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Portfolio
 
 
     
 
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback